|
Peru
|
18.5 Insulins and Other Anti-Diabetics
|
No observations
|
|
Ecuador
|
Essential Medicines List - Ecuador
|
No observations
|
|
Cuba. Cuadro Básico de Medicamentos 2018. Ministerio de Salud Pública.
|
CUADRO BÁSICO DE MEDICAMENTOS 2018. Ministerio de Salud Pública.
|
Others observations:
X 10 TABLETAS.
|
|
Costa Rica. Caja Costarricense de Seguro Social. 2019
|
39. Hipoglucemiantes e hiperglucemiantes
|
No observations
|
|
Mexico. Cuadro Basico de Medicamentos - 2017
|
05. ENDOCRINOLOGIA Y METABOLISMO
|
No observations
|
|
Mexico. Cuadro Basico de Medicamentos - 2017
|
05. ENDOCRINOLOGIA Y METABOLISMO
|
No observations
|
|
El Salvador - 2019
|
DROGAS USADAS EN DIABETES
|
No observations
|
|
Brasil. Relação Nacional de Medicamentos Essenciais. 2020
|
A. APARELHO DIGESTIVO E METABOLISMO
|
No observations
|
|
Chile. Formulario Nacional de Medicamentos. 2005
|
17.06. MEDICAMENTOS USADOS EN EL TRATAMIENTO DE LA DIABETES MELLITUS
|
No observations
|
|
Guyana. Essential Medicines List. 2020-2021
|
Insulins and Other Antidiabetic Medicines
|
No observations
|
|
Organisation of Eastern Caribbean States. Medical Products List. 2019-2021
|
8:20 Antidiabetic agents
|
No observations
|
|
Suriname. NGK-C-011
|
18.0 Blood sugar regulating agents
|
No observations
|
|
Haiti. National List of Essential Medicines
|
18.04 Antidiabetics and other drugs used in diabetes
|
No observations
|
|
Barbados. Barbados National Drug Formulary (BNDF)
|
68.20.20 Sulphonylureas
|
No observations
|
|
Bahamas. Drug Formulary
|
08.03. Insulin and Oral Antidiabetic Agents
|
No observations
|
|
Belize. National Drug Formulary
|
18.07 Insulins and other antidiabetic agents
|
No observations
|
|
Cayman Islands Health Services Authority Pharmacy Drug Formulary
|
06.01.02.01 Sulfonylureas
|
No observations
|
